Lyons Gary A
CIK 0001123343
Director
Filings
29
Latest May 29, 2026
Issuers covered
5
Showing
29 of 29
Page 1
Track record
12 of 12 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 12 | 42% | -2.1% | -0.6% | +19.5% | -18.8% |
| 90 days | 11 | 27% | -3.3% | -5.4% | +21.0% | -24.6% |
| 180 days | 11 | 27% | -7.7% | -14.9% | +21.2% | -21.7% |
| 365 days | 10 | 30% | -14.7% | -7.1% | +14.2% | -71.6% |
Issuers
Companies where Lyons Gary A has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| NBIX | Neurocrine Biosciences Inc | 16 | May 29, 2026 |
| TVTX | Travere Therapeutics, Inc. | 7 | May 21, 2026 |
| ELDN | Eledon Pharmaceuticals, Inc. | 3 | May 2, 2023 |
| RIGL | Rigel Pharmaceuticals Inc | 2 | Jul 12, 2023 |
| FRTX | Fresh Tracks Therapeutics, Inc. | 1 | May 17, 2022 |
All filings
29 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|